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Abstract
Background: The heme acquisition machinery in Streptococcus pyogenes is believed to consist of
the surface proteins, Shr and Shp, and heme-specific ATP-binding cassette transporter HtsABC.
Shp has been shown to rapidly transfer its heme to the lipoprotein component, HtsA, of HtsABC.
The function of Shr and the heme source of Shp have not been established.
Results: The objective of this study was to determine whether Shr binds heme and is a heme
source of Shp. To achieve the objective, recombinant Shr protein was prepared. The purified Shr
displays a spectrum typical of hemoproteins, indicating that Shr binds heme and acquires heme from
Escherichia coli hemoproteins in vivo. Spectral analysis of Shr and Shp isolated from a mixture of Shr
and heme-free Shp (apoShp) indicates that Shr and apoShp lost and gained heme, respectively;
whereas Shr did not efficiently lose its heme in incubation with apoHtsA under the identical
conditions. These results suggest that Shr directly transfers its heme to Shp. In addition, the rates
of heme transfer from human hemoglobin to apoShp are close to those of simple ferric heme
dissociation from hemoglobin, suggesting that methemoglobin does not directly transfer its heme
to apoShp.
Conclusion:  We have demonstrated that recombinant Shr can acquire heme from E. coli
hemoproteins in vivo and appears to directly transfer its heme to Shp and that Shp appears not to
directly acquire heme from human methemoglobin. These results suggest the possibility that Shr is
a source of heme for Shp and that the Shr-to-Shp heme transfer is a step of the heme acquisition
process in S. pyogenes. Further characterization of the Shr/Shp/HtsA system would advance our
understanding of the mechanism of heme acquisition in S. pyogenes.
Background
Specific ATP-binding cassette (ABC) type transporters are
involved in acquisition of essential iron in various forms
in bacterial pathogens. The substrate-binding component
of the ABC transporters specifically binds free Fe3+, ferric
siderophore complex, or heme, which is transported
across the cytoplasmic membrane by the permease com-
ponent using the energy from the hydrolysis of ATP cata-
lyzed by the ATPase component [1]. The human pathogen
Streptococcus pyogenes produces three ABC transporters,
FtsABCD [2], HtsABC or SiaABC [3,4], and MtsABC [5],
which acquire ferric ferrichrome, heme, and Fe3+  and
Mn2+, respectively. Expression of htsABC and mtsABC are
negatively regulated by the same metalloregulator MtsR in
response to levels of Fe only and Fe or Mn, respectively
[6,7].
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Heme is abundant in mammalian hosts and a preferred
iron source for bacterial pathogens [8-11]. Besides heme-
specific ABC transporters, cell surface heme-binding pro-
teins are required for heme acquisition in Gram-positive
pathogens. These proteins have been identified in S. pyo-
genes [12], Staphylococcus aureus [13], and Streptococcus equi
[14]. Heme is usually bound to host proteins at extremely
high affinities [15,16]. Furthermore, Gram-positive bacte-
ria have thick cell walls, and heme-specific ABC transport-
ers are most likely buried in the cell wall. Thus, heme
acquisition machinery in Gram-positive bacteria may
have to have evolved mechanisms to overcome these
obstacles in heme acquisition, i.e. inability of host hemo-
proteins to reach the ABC transporters and the extremely
high affinity of host proteins for heme. The cell surface
heme-binding proteins are believed to have evolved to
overcome these obstacles in heme acquisition in Gram-
positive pathogens. However, how these proteins are
involved in heme acquisition is largely unknown.
S. pyogenes is capable of utilizing heme derived from
human hemoproteins as a source of iron [9,17]. The heme
acquisition machinery in S. pyogenes is believed to consist
of Shr, Shp, and HtsABC. Shp and HtsABC are the cell sur-
face heme-binding protein and heme-specific ABC trans-
porter, respectively [4,12]. Shr, another cell surface
protein, is proposed to be a receptor of host hemoproteins
[3]; however, its function has not been firmly established.
We have been studying the S. pyogenes heme acquisition
machinery as a model system for understanding the heme
acquisition process in Gram-positive pathogens. Shp rap-
idly and directly transfers its heme to HtsA, the lipopro-
tein component of HtsABC, in a concerted two-step
process with one kinetic phase [18,19]. The structure of
the Shp heme-binding domain reveals that the Shp heme
iron is ligated to Met66 and Met153 [20], and the Met
axial ligands are both important for rapid heme transfer
from Shp to HtsA [21]. However, the heme source of Shp
is not known.
We have proposed that Shp functions to relay heme from
host proteins or another S. pyogenes heme-binding protein
to HtsABC [18]. In this study, we found that the rates of
ferric heme transfer from oxidized hemoglobin (methe-
moglobin) to heme-free Shp (apoShp) are similar to those
for the dissociation of ferric heme from methemoglobin,
suggesting that Shp cannot directly acquire heme from
methemoglobin and that Shp may mainly acquire heme
from another S. pyogenes protein. We hypothesize that this
protein is Shr. To test this hypothesis, recombinant Shr
was prepared and characterized. We found that Shr indeed
binds heme and, more interestingly, efficiently transfers it
to Shp but inefficiently to HtsA. These findings suggest the
possibility that Shr is the heme source of Shp and that
heme transfer from Shr to Shp is part of the heme acquisi-
tion process in S. pyogenes.
Results
Shp appears to indirectly acquire ferric heme from 
methemoglobin
Heme-binding form of Shp (holoShp) was formed in the
incubation of apoShp with human methemoglobin [18].
It was not known whether the formation of holoShp was
due to direct heme transfer from methemoglobin or indi-
rect scavenge of ferric heme dissociated from methemo-
globin. To examine this issue, the rate for formation of
holoShp was compared with that of heme dissociation
from methemoglobin. Limited methemoglobin (total 5.8
µM heme) was incubated with 7 to 56 µM apoShp at
25°C, and the formation of holoShp was monitored by
absorbance change at 405 and 425 nm, which present the
loss and gain of heme by methemoglobin and apoShp,
respectively. The time courses of normalized absorbance
change, ∆(A425-A405), fit a two exponential equation (Fig.
1A), but not a single exponential equation (Fig. 1B). Fit-
ting of the data to a two exponential equation resulted in
two first-order rate constants. The values of the rate con-
stants did not change significantly with [apoShp] from 7
to 56 µM, giving the mean values ± standard deviation of
0.0065 ± 0.0013 and 0.00041 ± 0.00012 s-1 for the rate
constants of the fast and slow phases, respectively. The
biphasic kinetics and rate constants are similar to those in
the dissociation of heme from methemoglobin using
H64Y/V68F apomyoglobin as a heme scavenger [22], in
which the fast and slow phases are heme dissociation
from the β and α subunits, respectively [22,23]. To con-
firm these similarities, the dissociation of heme from
methemoglobin using H64Y/V68F apomyoglobin was
performed under the same conditions. ∆(A425-A410) asso-
ciated with the loss and gain of heme by methemoglobin
and apomyoglobin, respectively, was kinetically biphasic
with 0.0058 ± 0.0002 and 0.00049 ± 0.00001 s-1 for the
rate constants of the fast and slow phases, respectively
(Fig. 1A). These rate constants are close to those in the
methemoglobin/apoShp reaction. These results suggest
that Shp does not directly acquire heme from human
methemoglobin.
Recombinant Shr protein
Since Shp appears not to directly acquire heme from
methemoglobin, the heme source of Shp may be a S. pyo-
genes protein. We speculated that this protein was Shr. If
this is true, Shr should bind heme and transfer it to Shp.
To test this idea, we first prepared recombinant Shr pro-
tein. In comparison with Escherichia coli containing the
empty vector, E. coli containing plasmid pET-His2-shr
with the cloned shr gene displayed an extra band in SDS
PAGE, which had approximately the expected molecular
weight of Shr (theoretical molecular weight = 139,406)BMC Microbiology 2008, 8:15 http://www.biomedcentral.com/1471-2180/8/15
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(Fig. 2). The band was obvious but not dominant, indicat-
ing moderate expression of Shr. The deduced amino acid
sequence of the cloned shr gene has a 6xHis tag and pre-
dicted net charge of +7.6 at pH 7.0. As expected, the
expressed protein bound to a cation exchange column of
SP Sepharose at pH 8.0 and Ni+-NTA column. Shr
obtained had a purity of 80% according to the densities of
the bands in SDS-PAGE analysis (lane 4 in Fig. 2). To con-
firm that the protein purified was not an E. coli protein,
the proteins of E. coli/pET-His2 (vector control) obtained
using SP Sepharose chromatography, the first step in the
Shr purification, was analyzed by SDS PAGE, and no pro-
tein with the size of Shr was detected (lane 5 in Fig. 2). The
purified protein sample was also probed with convales-
cent sera from 3 patients of streptococcal pharyngitis and
an individual without S. pyogenes exposure by Western
blotting analysis. All three patients, but not the control
individual, had antibodies specific for the purified protein
(Fig. 3), further supporting that the purified protein was
Shr. Thus, recombinant Shr can be expressed at moderate
levels in E. coli.
Shr binds heme
The pellet of E. coli expressing Shr was in light red color.
Purified Shr was yellow and red at diluted and concen-
trated concentrations, respectively, while the proteins
obtained from the control E. coli from the SP Sepharose
chromatography did not have absorption in the visible
region, indicating that Shr has an associated chromo-
phore. In the presence of excess dithionite, the protein
displays the absorption peaks at 426, 528, and 560 nm
Evidence for indirect heme transfer from human methemo- globin to apoShp Figure 1
Evidence for indirect heme transfer from human 
methemoglobin to apoShp. Methemoglobin (total 5.8 µM 
heme) was reacted with 28 µM apoShp or 40 µM H64Y/V68F 
apomyoglobin in 20 mM Tris-HCl, pH 8.0, and 0.45 M 
sucrose, and absorbance time courses at 425 and 405 or 410 
nm were recorded. (A) The normalized spectral changes 
∆(A425-A405) (green curve) and ∆(A425-A410) (red curve) for 
the methemoglobin/apoShp and methemoglobin/apomy-
oglobin reactions, respectively. The black curves are the the-
oretical curves obtained by fitting the data to a two 
exponential equation. (B) ∆(A425-A405) of the methemo-
globin/apoShp reaction does not fit a single exponential equa-
tion. The dashed and solid curves are respectively the 
observed data and theoretical curve from fitting of the data 
to a single exponential equation.
































SDS-PAGE showing expressed and purified recombinant Shr Figure 2
SDS-PAGE showing expressed and purified recom-
binant Shr. Lanes: 1, protein standards; 2, E. coli with empty 
vector (control); 3, E. coli containing Shr; 4, purified Shr; 5, 
proteins isolated from control E. coli using the first step of 
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(Fig. 4), a spectrum typical of ferrous heme in a hexacoor-
dinate form, indicating that the chromophore is heme.
Shr as isolated had a broad Soret peak and the small
resolved α band at 560 nm, suggesting that the protein
was a mixture of ferric and ferrous heme complexes. To
confirm this, the protein was incubated with ferricyanide,
and excess ferricyanide was removed from the protein by
a G-25 Sepharose column. The Soret peak of the ferri-
cyaide-treated Shr was indeed shifted to that of ferric
heme complex (Fig. 3), indicating that Shr as isolated was
a mixture of ferric and ferrous heme complexes. The
results of the pyridine hemochrome assay further confirm
that the chromophore is heme. The spectrum of the
chromophore derived from Shr in this assay was identical
to the one of pyridine hemochrome derived from an
authentic hemoprotein (data not shown). The molar ratio
of associated heme to Shr was 0.8 after adjustment accord-
ing to the estimated purity of the purified Shr. These
results indicate that the chromophore associated with Shr
is heme and that Shr can acquire heme from E. coli hemo-
proteins in vivo.
Heme transfer from Shr to apoShp
We next tested whether Shr transfers its heme to apoShp.
HoloShr (10 µM) and 75 µM apoShp were incubated for
15 min, and the two proteins were separated as described
in the Methods section. SDS-PAGE analysis confirmed the
separation of the two proteins (Fig. 5A). HoloShp was
present in the isolated Shp sample, as evidenced by the
presence of absorption of bound heme (Fig. 5B). Thus,
apoShp gained heme in its reaction with Shr. The ratio of
A410/A280 of the treated Shr was 29% of that of the starting
Shr (Fig. 5C). A410 is the absorbance of bound heme, and
A280 is mainly the absorbance of the protein moiety. Thus,
A410/A280 can be used to approximately estimate relative
levels of heme in the protein samples. The lower A410/A280
ratio of the treated Shr indicates that Shr lost heme in its
reaction with apoShp. These results suggest that Shr trans-
fers its heme to apoShp.
Shr does not efficiently transfer its heme to apoHtsA
To test whether Shr transfers its heme to apoHtsA, 15 µM
holoShr was incubated with 75 µM apoHtsA or apoShp
(positive control) for 2 min, and Shr was isolated from the
mixtures. The normalized spectrum of the isolated Shr
from its apoHtsA mixture was compared with those of
untreated Shr and Shr isolated from its mixture with
apoShp. As shown in Fig. 6, the ratio of A410/A280 of Shr
from the Shr/apoHtsA reaction was decreased from 1.05
to 0.91, whereas the A410/A280 ratio of Shr from the Shr/
apoShp reaction was lowered from 1.05 to 0.3. According
the extinction coefficients of holoShr and apoShr at 280
and 408 nm and these A410/A280 ratios, Shr lost 14% and
73% heme in its reactions with apoHtsA and apoShp,
respectively. These results indicate that Shr transfers its
heme to apoShp more efficiently than to apoHtsA.
Discussion
One of the major findings of this study is that Shr binds
heme. Purified Shr has a chromophore and displays a vis-
ible absorption spectrum typical of hemoproteins. Reduc-
tion of Shr with dithionite results in the spectrum typical
of bound ferrous heme in a hexacoordinate complex. The
hemochrome assay also resulted in hemochrome from
Shr. These findings indicate that Shr binds heme and can
acquire heme from E. coli hemoproteins.
Western blots showing the presence of Shr-specific antibod- ies in convalescent sera from patients of streptococcal phar- yngitis Figure 3
Western blots showing the presence of Shr-specific 
antibodies in convalescent sera from patients of 
streptococcal pharyngitis. Purified Shr (50 ng/lane) was 
resolved by SDS PAGE and analyzed by Western blotting 
using convalescent sera from three pharyngitis patients (lanes 
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Spectral evidence for that Shr binds heme Figure 4
Spectral evidence for that Shr binds heme. Presented 
are the spectra of 15 µM Shr isolated (black solid curve), 
treated with 50 µM ferricyanide (red curve), and reduced by 
excess dithionite (dashed line) in 20 mM Tris-HCl, pH 8.0.
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Andrade et al. [24] identified a domain in genes near the
components of a putative Fe3+ siderophore transporter
(designated NEAT domain) from Gram-positive patho-
genic bacteria. It should be pointed out that the transport-
ers in S. pyogenes and S. aureus referred in the work of
Andrade et al. were later found to be heme transporters
[4,13]. Shr, which was referred to S_pyog in this reference,
has two NEAT domains. The NEAT domain in S. aureus
surface proteins IsdA and IsdC binds heme [25,26],
whereas the NEAT domain of IdsH does not bind heme
[27], suggesting that the binding of heme to Shr may be
mediated by one or both NEAT domains.
Another major finding is that Shr appears to directly trans-
fer its heme to apoShp. When Shr was incubated with
apoShp or apoHtsA under the same conditions, the
majority of Shr lost heme to apoShp, but not to apoHtsA.
The apparent bimolecular rate constant for binding of fer-
ric heme to apoHtsA at low [ferric heme] (k = 80 µM-1s-1)
is 50 times as that for binding of ferric heme to apoShp (k
= 1.6 µM-1s-1), and the association constant for HtsA-ferric
heme complex (K = 31,000 µM-1) is 5-fold greater than
that for Shp-ferric heme complex (K = 5,300 µM-1) [19].
Based on these previous kinetic and equilibrium con-
stants, the efficient and inefficient heme transfer from Shr
to apoShp and from Shr to apoHtsA, respectively, suggests
that Shr directly transfers its heme to apoShp and indi-
rectly and inefficiently to apoHtsA. Otherwise, Shr would
release heme into solvent, which should be caught more
efficiently by apoHtsA than apoShp, and Shr should thus
lose heme to apoHtsA and apoShp at least to similar
extent.
The dissociation of ferric heme from methemoglobin has
been found to be a slow process with two kinetic phases
using H64Y/V68F apomyoglobin as a heme scavenger
[22]. In this reaction, methemoglobin dissociates heme
into solvent, which is caught by the mutant apomy-
oglobin, and the fast and slow phases are the dissociation
of heme from the β and α subunits, respectively [22,23].
The time courses of absorbance change in the reactions of
methemoglobin with apoShp and apomyoglobin were
almost overlaid with similar rate constants. In addition,
the rate constants of the two kinetic phases of the methe-
moglobin/apoShp reaction did not significantly change
with [apoShp]. These observations suggest that apoShp
Heme transfer from Shr to apoShp Figure 5
Heme transfer from Shr to apoShp. ApoShp(75 µM) was incubated with 10 µM Shr in 0.1 ml of 20 mM Tris-HCl, pH 8.0, 
at room temperature for 15 min. The sample was then loaded onto a 0.1-ml SP Sepharose column and eluted as described in 
the text. (A) SDS-PAGE analysis showing separation of Shr and Shp from their mixture. Lanes: 1, Shr/apoShp mixture before 
separation; 2, Shr isolated from the mixture; 3, Shp isolated from the mixture. (B) Spectra of apoShp (solid curve) and treated 
Shp (dashed curve). (C) Spectra of Shr (solid curve) and treated Shr (dashed curve). The arrows in panels B and C indicate the 
Y-axis of the corresponding spectrum.
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does not directly, but indirectly, get heme from methemo-
globin. Thus, the heme source of Shp in vivo is most likely
Shr.
We have reported the direct heme transfer from Shp to
HtsA [18,19], the only example of heme transfer from a
surface protein to ABC transporter. Now we have found
heme transfer from a cell surface protein to another cell
surface protein. These new findings provide opportunity
to fully elucidate the molecular mechanism of heme
acquisition in S. pyogenes. We propose that Shr acquires
heme from host proteins and that Shp relays heme from
Shr to HtsA. We are currently in process to investigate
whether methemoglobin directly transfers its heme to Shr
and whether Shp facilitates heme transfer from Shr to
HtsA. Although S. pyogenes Shr and Shp have homolog
only in S. equi [14] among the bacteria with known
genome sequences currently, the hemoglobin receptor
IsdB of S. aureus [28] is a cell surface protein and binds
heme [13]. S. aureus has additional cell surface heme-
binding proteins. It is most likely that S. pyogenes and S.
aureus  follow similar mechanism of heme transfer,
although the proteins involved are not homologous in
amino acid sequence. This idea is supported by the simi-
larity in the structures of the Shp heme-binding domain
and the NEAT domain of IsdA and IsdC [20,25,26] and by
the homology between S. pyogenes HtsA and S. aureus IsdE
[29]. Indeed, IsdA rapidly and directly transfers its heme
to IsdC in a kinetic mechanism [30] that is similar to that
of heme transfer from Shp to HtsA [19]. Thus, the detailed
biochemical mechanism of heme transfer in the S. pyo-
genes heme acquisition system may serve as a model for
heme acquisition in Gram-positive pathogens.
Conclusion
Shr binds heme in a hexacoordinate form and acquires
heme from E. coli hemoproteins in vivo. Shr efficiently
transfers its heme to Shp, but not to HtsA, under the same
conditions, suggesting that Shr-to-Shp heme transfer is
direct. In contrast, Shr does not directly acquire heme
from human methemoglobin. These results suggest the
possibility that Shr, but not methemoglobin, is a source of
heme for Shp in vivo and that the Shr-to-Shp heme trans-
fer is a step of the heme acquisition process in S. pyogenes.
Methods
Materials
All chemicals were purchased from Sigma (St. Louis, Mo.).
Pfu Ultra high-fidelity DNA polymerases used for PCR
cloning was from Stratagene. SP Sepharose, DEAE Sepha-
rose, and phenyl Sepharose were obtained from GE
Healthcare (Piscataway, NJ). E. coli strains NovaBlue and
BL21 (DE3) (Novagen, Madison, Wis.) were used as hosts
for gene cloning and protein expression, respectively. All
solutions used in protein purification and heme-transfer
reactions were buffered with 20 mM Tris-HCl, pH 8.0.
Human hemoglobin was purchased from ICN Pharma-
ceuticals, Inc. Heme-free H64Y/V68F sperm whale
myoglobin was prepared as described [22].
Gene cloning
The shr gene was cloned from a serotype M1 GAS strain
MGAS5005 [31] in two steps because of its large size. The
3' fragment of shr was amplified by PCR with primers 5'-
CAGCCATGGGAGGTCAAGAAAGTG-3' and 5'-TGAAT-
TCTAGTGATAACGAGAGCTACTTTC-3'. The PCR product
was digested with NcoI and EcoRI and ligated into pET-
His2 [31] to create pET-His2-shr3'f. The 5' fragment of shr
was amplified using primers 5'-ATCCATGGCTCAAACTG-
TAAAATCACAAGAG-3' and 5'-CTCCCATGGCTGATAC-
CAAAAC-3' and cloned into the NcoI site of pET-His2-
shr3'f, to yield pET-His2-shr. No amino acid replacement
was introduced by this strategy. The cloned shr gene had
no spurious mutations according to DNA sequencing. The
proteins made from pET-His2-shr lacked the putative
secretion signal sequence (amino acids 1–21) and the
charged tail and transmembrane domain at the carboxyl
terminus (amino acids 1252 to 1275) and had 12 amino
acid residues, MHHHHHHLETMA, fused to the first
amino acid residue (Q22) of the mature protein.
Expression and purification of recombinant Shr
For expression of Shr, E. coli BL21 (DE3) cells containing
pET-His2-shr were grown in 8 liters of Luria-Bertani broth
supplemented with 100 mg/l ampicillin at 37°C to an
Inefficient heme transfer from Shr to apoHtsA Figure 6
Inefficient heme transfer from Shr to apoHtsA. Apo-
HtsA or apoShp (75 µM) was incubated with 15 µM Shr in 
0.1 ml of 20 mM Tris-HCl, pH 8.0, at room temperature for 
2 min. Each sample was then loaded onto a 0.1-ml SP Sepha-
rose column and eluted as described in the text. Presented 
are the normalized spectra of Shr without or with treatment 
with apoHtsA or apoShp. The normalization was done by 
setting A280 = 1.0.
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OD600  of approximately 1.0, and Shr expression was
induced with 0.5 mM IPTG for 8 h. Bacteria were har-
vested by centrifugation for 10 min at 4,000 × g. The cell
paste was resuspended in 120 ml of Tris-HCl containing 1
mM phenylmethylsulfonyl fluoride, a protease inhibitor,
sonicated on ice for 15 min, and centrifuged at 15,000 × g
for 20 min to remove cell debris. The supernatant was
loaded onto a SP Sepharose column (2 × 10 cm) equili-
brated in Tris-HCl and washed with 100 ml Tris-HCl. The
protein was eluted from the column with a 200-ml gradi-
ent of 0 to 500 mM NaCl. The fractions containing Shr
were pooled, dialyzed against Tris-HCl, loaded onto a
DEAE Sepharose column (1.5 × 4 cm), and washed with
100 ml Tris-HCl. Flow-through containing Shr was col-
lected. (NH4)2SO4 was added to the flow-through to a
final concentration of 1.2 M, the sample was applied onto
a phenyl Sepharose column (1.5 × 10 cm), and the col-
umn was washed with 50 ml of 1.0 M (NH4)2SO4 and
eluted with a 70-ml linear gradient of 1.0 M to 0.2 M
(NH4)2SO4. Fractions containing Shr were pooled and
dialyzed against 3 l Tris-HCl at 4°C for 24 h. Shr was con-
centrated using Centricon Plus 20 filtration devices (Mill-
ipore, Bedford, MA).
Preparation of apoShp
Recombinant Shp was expressed as described previously
[12]. Portion of recombinant Shp was in inclusion bodies
and recovered as pellet after lysis by sonication. Insoluble
Shp from 6 liters of culture was dissolved in 20 ml of 8 M
urea, and the denatured Shp was refolded by dialysis
against 3 l Tris-HCl. The refolded Shp was loaded onto an
SP Sepharose column (2.5 × 3 cm), and the column was
washed with 50 ml Tris-HCl and eluted with a 100-ml lin-
ear gradient of 0 to 150 mM NaCl. Fractions containing
apoShp were pooled, dialyzed against 3 l Tris-HCl, and
loaded onto a DEAE Sepharose column (2.5 × 2.5 cm).
The column was washed with 50 ml Tris-HCl and eluted
with a 100-ml linear gradient of 0 to 300 mM NaCl. Shp
eluted was dialyzed against Tris-HCl and concentrated
using Centricon Plus 20 filtration devices. Shp obtained
was in apo-form and had a purity of >95% according to
SDS-PAGE analysis.
Western blotting analysis
The presence of Shr-specific antibody in convalescent sera
of patients was assessed by Western blotting analysis, as
described previously [32]. Convalescent-phase serum
samples were obtained from 3 patients with streptococcal
pharyngitis at about 21 days after diagnosis. The protocol
for the collection and analysis of the sera was approved by
the Institutional Review Board at Montana State Univer-
sity, Bozeman.
Determination of heme and protein contents
Protein concentrations were determined using a modified
Lowry protein assay kit (Pierce, Rockford, IL) with bovine
serum albumin as a standard. Heme content was meas-
ured using a pyridine hemochrome assay [33]. Briefly,
protein sample in 750 µl of Tris-HCl was mixed with 175
µl pyridine, 75 µl of 1 N NaOH, and approximately 2 mg
sodium hydrosulfite. The optical spectrum was then
immediately recorded. The heme content was determined
using the extinction coefficient ε418 = 191.5 mM-1 cm-1. All
absorption spectra were obtained using a SPECTRAmax
384 Plus spectrophotometer (Molecular Devices, Sunny-
vale, CA).
Heme transfer from human methemoglobin to apoShp
The procedure for measurement of heme dissociation
from methemoglobin using H64Y/V68F apomyoglobin
as a heme scavenger [22] was followed for the hemo-
globin/apoShp reaction. Methemoglobin (total 5.8 µM
heme) was reacted at 25°C with 7, 14, 28, or 56 µM
apoShp in 20 mM Tris-HCl and 0.45 M sucrose. Absorb-
ance traces at 405 and 425 nm were recorded. Spectral
change ∆(A425-A405) was analyzed by fitting to a two expo-
nential expression to get two rate constants for the fast
and slow phases. As a control, the reaction of methemo-
globin (5.8 µM heme) with 40 µM H64Y/V68F apomy-
oglobin was also performed under the identical
conditions, and absorbance traces at 410 and 425 nm
were recorded and analyzed as in the methemoglobin/
apoShp reaction.
Heme transfer from Shr to apoShp or apoHtsA
Shr at 10 or 15 µM was incubated with 75 µM apoShp or
apoHtsA at 25°C for 2 or 15 min. The proteins in the mix-
tures were separated as follows. In the Shr/apoShp reac-
tion, the incubated mixture was loaded onto a small SP
Sepharose column (~0.1 ml resin), and the column was
washed with 2 ml Tris-HCl. Shp was first eluted from the
column with 2 ml of 50 mM NaCl, and Shr was then
eluted with 2 ml of 200 mM NaCl. In the Shr/apoHtsA
reaction, the mixture was loaded onto a small SP Sepha-
rose column (~0.1 ml resin), and the column was washed
with 2 ml Tris-HCl. HtsA did not bind to the column and
was washed out by Tris-HCl, and Shr was then eluted out
with 2 ml of 200 mM NaCl. The separation of the two pro-
teins was confirmed by SDS-PAGE analysis, and the loss
and gain of heme by Shr and apoShp or apoHtsA, respec-
tively, were assessed by UV-visible spectra of the separated
proteins.
Nucleotide sequence accession number
The GenBank accession number for the nucleotide
sequence of the S. pyogenes shr gene is EU098089.BMC Microbiology 2008, 8:15 http://www.biomedcentral.com/1471-2180/8/15
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